NASDAQ / LIVE COMPANY INTELLIGENCE

Beta Bionics, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERBBNX
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / BBNX COVERAGE

What’s moving Beta Bionics, Inc. now

Current reporting with the operating signal separated from the noise.

01
Beta Bionics, Inc. (BBNX) Q2 2026 Earnings Call Transcript

Beta Bionics, Inc. (BBNX) Q2 2026 Earnings Call Transcript

Investors are testing whether Beta Bionics, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
02
Beta Bionics, Inc. (BBNX) Q2 2026 Earnings

Beta Bionics, Inc. (BBNX) Q2 2026 Earnings

Investors are testing whether Beta Bionics, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
03
Will Beta Bionics, Inc. (BBNX) Report Negative Earnings Next Week? What You Should Know

Will Beta Bionics, Inc. (BBNX) Report Negative Earnings Next Week? What You Should Know

Investors are testing whether Beta Bionics, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
04
Securities Fraud Investigation Into Beta Bionics, Inc. (BBNX) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

Securities Fraud Investigation Into Beta Bionics, Inc. (BBNX) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

The story matters when it changes Beta Bionics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
05
Beta Bionics, Inc. (BBNX) Reports Q3 Earnings: What Key Metrics Have to Say

Beta Bionics, Inc. (BBNX) Reports Q3 Earnings: What Key Metrics Have to Say

Investors are testing whether Beta Bionics, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
PRIMARY DOCUMENTS / SEC EDGAR

Latest BBNX filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-07-29 · Period 2026-06-30SEC ↗10-QQuarterly financial reportFiled 2026-04-21 · Period 2026-03-31SEC ↗10-KAnnual financial reportFiled 2026-02-24 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-29 · Period 2026-07-29SEC ↗8-KMaterial company eventFiled 2026-05-22 · Period 2026-05-21SEC ↗8-KMaterial company eventFiled 2026-05-21 · Period 2026-05-21SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-10 · Period 2026-05-21SEC ↗SCHEDULE 13GOfficial SEC filingFiled 2026-07-24SEC ↗
EARNINGS / QUARTERLY TRACKER

Beta Bionics, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.